Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes
US6187771A · kind A · utility
15Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 1999 |
| Grant date | Feb 13, 2001 |
| Priority date | — |
| Expiry date | Jun 23, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/0202
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to novel tricyclic ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions of such tricyclic compounds, plus the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, and for the prevention of ischemic injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.